Amundi’s Kodiak Sciences KOD Stock Holding History

Amundi’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,124	Closed	-$16K	–	1690
2022 Q1	$16K	Sell	2,124 -230	-10%	-$8.98K	﹤0.01%	1616
2021 Q4	$148K	Hold	2,354	–	–	﹤0.01%	1521
2021 Q3	$226K	Hold	2,354	–	–	﹤0.01%	1424
2021 Q2	$219K	Buy	+2,354	New	+$226K	﹤0.01%	1364

Other funds holding KOD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Amundi's KOD Position: Q2 2022 in Review

Amundi sold out of Kodiak Sciences (KOD) in Q2 2022, closing a stake of 2,124 shares — an estimated $16K sold.

Amundi first reported a position in KOD in Q2 2021 and held it in 4 quarters. The position peaked at $226K in Q3 2021. 131 funds tracked by Wall St. Rank hold KOD as of Q2 2022.

Amundi reported no remaining Kodiak Sciences position as of Q2 2022 after selling out during the quarter.
Amundi sold 2,124 Kodiak Sciences shares in Q2 2022, an estimated $16K.
Amundi first reported a position in Kodiak Sciences in Q2 2021 and held it in 4 quarters.
Amundi's Kodiak Sciences position peaked at $226K in Q3 2021.
131 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2022.

Based on Amundi's 13F filing for Q2 2022, filed 15 Aug 2022.